Company: CRNX
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0000950170-25-057452
Chunk: 70

Company: Crinetics Pharmaceuticals, Inc.
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 70
---
/1/2023      |     |             |  34,125 |     |               |  51,188 |     | -2 |    19.64 |       |     | 2/28/2033    |   |     |                |      — |     |                |         — |
|                           |     | 3/1/2023      |     |             |       — |     |               |       — |     |    |          |     — |     |              | — |     |                | 22,125 |     |                | 1,131,251 |
|                           |     | 2/28/2022     |     |             |  13,475 |     |               |   6,738 |     | -2 |    20.02 |       |     | 2/24/2032    |   |     |                |      — |     |                |         — |
|                           |     | 2/28/2022     |     |             |       — |     |               |       — |     |    |          |     — |     |              | — |     |                |  2,476 |     |                |   126,598 |
|                           |     | 9/1/2021      |     |             |  85,834 |     |               |  26,667 |     | -3 |    23.98 |       |     | 8/31/2031    |   |     |                |      — |     |                |         — |

(1) Market value is calculated based on the closing price of our common stock of $51.13 per share on December 31, 2024, the last trading day of 2024, times the number of shares subject to the stock award. (2) The stock options vest over a period of four years from the date of grant in equal monthly installments, subject to the

<div align='center'>51</div>

executive's continuous service through each vesting date. The stock options have a term of ten years from the date of grant. Vesting of each stock option is contingent upon the named executive officer’s continued service, except as may be accelerated on certain events described above under “—Discussion of Summary Compensation and Grants of Plan Based Awards Tables—Employment Agreements” and under “—Potential Payments Upon Termination